858-692-3573 info@denovicontx.com

Global Pharma R&D AI, Data Science and Informatics Summit

On November 16, 2020, Denovicon Therapeutics & CEO Founder, Scott Bembenek, will speak at the Global Pharma R&D AI, Data Science and Informatics Summit (PRADI 2020) on ‘Combining Machine Learning and Molecular Modeling for Enhanced Active Learning in...

Careers in Biotech Panel with Rady and UCSD PhD Students

On July 14, 2020, Denovicon Therapeutics Founder & CEO, Scott Bembenek, shared some of his experiences and insights from his scientific and entrepreneurial journeys (thus far) with Rady and UCSD students at Rady’s ‘Careers in Biotech’...

Our Commitment to COVID-19

As part of Denovicon Therapeutics’ commitment to COVID-19, we tasked our novel molecular modeling-artificial intelligence (AI) hybrid computational platform to find potential therapies from over 13,000 FDA-approved drugs and clinical candidates. The molecular modeling...